HB198 - Drug Pricing Transparency and Accountability Act
US Congress - 118th Congress
Introduced byMatt Rosendale
Last updated over 1 year ago
1 Co-Sponsor
To increase reporting requirements and transparency requirements in the 340B Drug Pricing Program, and for other purposes.
STATUS
Introduced
Verifications Required
You must be a verified voter to do that.
No Thanks, I'll do it later
Verify your identity now